Developments 4basebio launches enzymatic ssDNA platform 4basebio (AIM: 4BB) has announced the commercial launch of its high-capacity single-stranded DNA (ssDNA) product line to accelerate the development of safer, more precise genetic therapies by enabling targeted gene... May 11, 2026